A Study of Apatinib Tablets in the Treatment of Advanced or Metastatic Gastric Cancer

PHASE4CompletedINTERVENTIONAL

Enrollment

2,004

Participants

Timeline

Start Date

May 15, 2015

Primary Completion Date

May 29, 2020

Study Completion Date

September 3, 2020

Conditions

Advanced Gastric or Gastroesophageal Junction Adenocarcinoma

Interventions

DRUG

ApatinibTablets

Apatinib Tablets, recommended dose of 850mg

Trial Locations (2)

Fudan University cancer hospital, Shanghai

Nanjin Military 81 Hosiptal, Nanjing

All Listed Sponsors

lead

Jiangsu HengRui Medicine Co., Ltd.

INDUSTRY

NCT02426034 - A Study of Apatinib Tablets in the Treatment of Advanced or Metastatic Gastric Cancer | Biotech Hunter | Biotech Hunter